When a sponsor chooses to outsource an entire trial to a single CRO, I often wonder what will happen if the CRO doesn’t live up to expectations.

If all the knowledge of the study resides in one external team, there’s little room for error. Maybe the sponsor will replace the CRO the next time around. That leaves little recourse for the current study and its immediate challenges.

I’m a big proponent of the alternative best-of-breed approach. Imagine cherry-picking a team of experts. If one party underperforms, replacements can be found without overhauling the rest of the team and sacrificing the study as a whole. It’s a strategy gaining popularity because it’s self-regulating. Autonomy and interdependence raise the performance bar for everyone involved.

Dyad is a consulting firm focused on all phases and aspects of clinical trials. Dyad is not a CRO although some of the services do overlap services offered by most CRO’s. We’re in “the business of clinical trials”, meaning we keep the business dimension in mind as we solve or improve the clinical process.

By adopting a client centric point of view, Dyad has a unique approach to improving clinical trial results through greater efficiency and improved time to submittal. For instance, consider our data management services.  The mechanics of applying technology in the handling of CRF’s or eCRF’s is secondary to the value of the analysis and the client/site management that happens throughout the data collection phase of the trial.